Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA AUROBINDO PHARMA CIPLA/
AUROBINDO PHARMA
 
P/E (TTM) x 32.8 12.3 265.7% View Chart
P/BV x 4.0 1.3 299.4% View Chart
Dividend Yield % 0.5 1.6 30.2%  

Financials

 CIPLA   AUROBINDO PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-22
AUROBINDO PHARMA
Mar-22
CIPLA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0831,064 101.8%   
Low Rs806584 138.0%   
Sales per share (Unadj.) Rs269.7400.3 67.4%  
Earnings per share (Unadj.) Rs31.745.7 69.4%  
Cash flow per share (Unadj.) Rs44.864.9 68.9%  
Dividends per share (Unadj.) Rs5.009.00 55.6%  
Avg Dividend yield %0.51.1 48.5%  
Book value per share (Unadj.) Rs257.8419.4 61.5%  
Shares outstanding (eoy) m806.81585.94 137.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.52.1 170.1%   
Avg P/E ratio x29.818.0 165.2%  
P/CF ratio (eoy) x21.112.7 166.3%  
Price / Book Value ratio x3.72.0 186.5%  
Dividend payout %15.819.7 80.1%   
Avg Mkt Cap Rs m762,177482,799 157.9%   
No. of employees `000NANA-   
Total wages/salary Rs m35,29934,509 102.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,633234,555 92.8%  
Other income Rs m3,2173,226 99.7%   
Total revenues Rs m220,851237,781 92.9%   
Gross profit Rs m43,29842,566 101.7%  
Depreciation Rs m10,52011,265 93.4%   
Interest Rs m1,064486 218.6%   
Profit before tax Rs m34,93334,040 102.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3387,256 128.7%   
Profit after tax Rs m25,59526,784 95.6%  
Gross profit margin %19.918.1 109.6%  
Effective tax rate %26.721.3 125.4%   
Net profit margin %11.811.4 103.0%  
BALANCE SHEET DATA
Current assets Rs m147,108181,227 81.2%   
Current liabilities Rs m49,12981,560 60.2%   
Net working cap to sales %45.042.5 106.0%  
Current ratio x3.02.2 134.8%  
Inventory Days Days6325 250.9%  
Debtors Days Days662 9.2%  
Net fixed assets Rs m119,415155,104 77.0%   
Share capital Rs m1,614586 275.4%   
"Free" reserves Rs m206,364245,174 84.2%   
Net worth Rs m207,977245,760 84.6%   
Long term debt Rs m4,1622,492 167.0%   
Total assets Rs m266,523336,331 79.2%  
Interest coverage x33.871.0 47.7%   
Debt to equity ratio x00 197.4%  
Sales to assets ratio x0.80.7 117.1%   
Return on assets %10.08.1 123.4%  
Return on equity %12.310.9 112.9%  
Return on capital %17.013.9 122.0%  
Exports to sales %26.231.1 84.5%   
Imports to sales %8.211.9 68.6%   
Exports (fob) Rs m57,09472,862 78.4%   
Imports (cif) Rs m17,80327,965 63.7%   
Fx inflow Rs m60,18077,245 77.9%   
Fx outflow Rs m17,80331,524 56.5%   
Net fx Rs m42,37645,721 92.7%   
CASH FLOW
From Operations Rs m33,25950,165 66.3%  
From Investments Rs m-18,719-32,116 58.3%  
From Financial Activity Rs m-15,998-29,693 53.9%  
Net Cashflow Rs m-1,323-11,674 11.3%  

Share Holding

Indian Promoters % 13.5 48.8 27.7%  
Foreign collaborators % 20.1 3.1 655.7%  
Indian inst/Mut Fund % 49.0 38.0 128.9%  
FIIs % 27.6 20.7 133.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 48.2 137.8%  
Shareholders   418,910 359,684 116.5%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   DR. REDDYS LAB    SUN PHARMA    LUPIN    PIRAMAL ENTERPRISES    ZYDUS LIFESCIENCES    



Today's Market

Indian Share Markets End Flat; IT and FMCG Stocks Witness Selling(Closing)

Indian share markets traded in a rangebound manner throughout the day to end on a flat note.